These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11207632)

  • 1. Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study.
    Katznelson L; Kleinberg D; Vance ML; Stavrou S; Pulaski KJ; Schoenfeld DA; Hayden DL; Wright ME; Woodburn CJ; Klibanski A
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):183-8. PubMed ID: 11207632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH-induced LH hyporesponsiveness as a potential mechanism for hypogonadism in male patients with acromegaly.
    Nishio R; Takeshita A; Uchida T; Herai T; Sakamoto K; Shimizu Y; Arai M; Tatsushima K; Fukuhara N; Okada M; Nishioka H; Yamada S; Koibuchi N; Watada H; Takeuchi Y
    Endocr J; 2021 Aug; 68(8):953-968. PubMed ID: 33840669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
    Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly.
    Colao A; Pivonello R; Cappabianca P; Briganti F; Tortora F; Auriemma RS; De Martino MC; Marzullo P; Lombardi G
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):342-9. PubMed ID: 16117824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levels of growth hormone and prolactin in the blood before, during, and after selective transsphenoidal adenectomy in patients with acromegaly and hypophyseal prolactin-producing tumors].
    Sekso M; Vizner B; Reiner Z; Gnjidić Z; Skrablin-Kucić S; Brkić K
    Acta Med Iugosl; 1987; 41(4):229-44. PubMed ID: 3687487
    [No Abstract]   [Full Text] [Related]  

  • 6. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome.
    Jane JA; Starke RM; Elzoghby MA; Reames DL; Payne SC; Thorner MO; Marshall JC; Laws ER; Vance ML
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2732-40. PubMed ID: 21715544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly.
    Abe T; Lüdecke DK
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):27-35. PubMed ID: 10341853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
    Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of acromegaly. Clinical and immunocytochemical analysis in 75 patients.
    Laws ER; Scheithauer BW; Carpenter S; Randall RV; Abboud CF
    J Neurosurg; 1985 Jul; 63(1):35-8. PubMed ID: 4009272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
    Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A follow-up of 130 patients with acromegaly in a single centre.
    Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK
    Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of growth-hormone deficiency in acromegaly as a result of pituitary apoplexy.
    Rigolosi RS; Schwartz E; Glick SM
    N Engl J Med; 1968 Aug; 279(7):362-4. PubMed ID: 5662169
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients.
    Cordido F; Peñalva A; Martinez T; Casanueva FF; Dieguez C
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):509-13. PubMed ID: 11318787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of acromegaly by transsphenoidal surgery.
    Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
    Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
    Ahmed S; Elsheikh M; Stratton IM; Page RC; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 1999 May; 50(5):561-7. PubMed ID: 10468920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of pituitary magnetic resonance imaging in men with hypogonadism.
    Rhoden EL; Estrada C; Levine L; Morgentaler A
    J Urol; 2003 Sep; 170(3):795-8. PubMed ID: 12913700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical growth hormone and prolactin in pituitary adenomas causing acromegaly and their relationship to basal serum hormone levels and the growth response to thyrotrophin releasing hormone.
    Nieuwenhuijzen Kruseman AC; Bots GT; Roelfsema F; Frölich M; Van Dulken H
    Clin Endocrinol (Oxf); 1983 Jul; 19(1):1-8. PubMed ID: 6413097
    [No Abstract]   [Full Text] [Related]  

  • 20. Adolescent acromegaly: clinical parameters and treatment outcome.
    Bhansali A; Upreti V; Dutta P; Mukherjee KK; Nahar U; Santosh R; Das S; Walia R; Pathak A
    J Pediatr Endocrinol Metab; 2010 Oct; 23(10):1047-54. PubMed ID: 21158216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.